Biotech News
AN2 Therapeutics to Participate in 9th Annual Evercore Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 20, 2026-- AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom,
